Hyderabad, Feb 25 (Maxim News): Hyderabad-based Biological E. Limited (BE) announced a strategic partnership with Denmark-based Bavarian Nordic A/S to expand access to Bavarian Nordic’s Chikungunya Vaccine in low- and middle-income countries (LMICs).
As part of the agreement, there will be a technology transfer of the current drug product manufacturing process for the Chikungunya vaccine. There is also an option to transfer the drug substance process at a later stage. This collaboration aims to increase manufacturing capacity and ensure future vaccine supplies for endemic LMICs.
Following the initial technology transfer, regulatory approval applications will be submitted, with commercial manufacturing set to commence thereafter.
BE plans to upgrade its existing facilities in Genome Valley, Hyderabad to support vaccine production. This expansion is expected to create up to 300 new jobs, according to a press release.
Leaders Speak on the Partnership
Mahima Datla, Managing Director of Biological E. Limited, stated:
“Our manufacturing scale and proven track record in providing global vaccine access align synergistically with Bavarian Nordic through this strategic partnership.”
Paul Chaplin, President and CEO of Bavarian Nordic, emphasized the importance of this collaboration:
“Expanding supply is essential to meet the growing demand for effective solutions to prevent Chikungunya in vulnerable populations across endemic regions. We are committed to building strong partnerships to help achieve this goal.”
About the Vaccine
The CHIKV VLP is an adjuvanted VLP recombinant protein vaccine designed for active immunization against Chikungunya virus (CHIKV) in individuals aged 12 years and older. Since the vaccine contains no viral genetic material, it cannot infect cells, reproduce, or cause disease.
In February 2025, the U.S. Food and Drug Administration (USFDA) approved VIMKUNYA (CHIKV VLP), marking it as the first Chikungunya vaccine authorized for individuals aged 12 and above. The approval was based on the results of two Phase 3 clinical trials involving over 3,500 healthy participants aged 12 and older. (Maxim News)
More Stories…
Pan Shop Theft Case: Mailardevpally Police Arrest Two Persons
Hyderabad, April 14 (Maxim News): Mailardevpally Police arrested two persons for allegedly breaking into a pan shop and committing theft. Here To Join Us On WhatsApp Police also recovered stolen property, tools, and a vehicle used in the offence. The case surfaced after complainant Sohail Pasha reported a break in at his pan shop. The…
Counterfeit Currency Case: Hyderabad Police Arrest Accused
Hyderabad, April 14 (Maxim News): Chaderghat Police arrested a man for circulating counterfeit currency and seized fake notes worth ₹94,000. Here To Join Us On WhatsApp The accused, Ahmed Pasha, a resident of Chandrayangutta, allegedly planned to circulate the fake currency as genuine. Police registered a case under relevant sections of the Bharatiya Nyaya Sanhita.…
Hyderabad: Kavitha Sends Chadar to Ajmer Dargah
Hyderabad, April 14 (Maxim News): K. Kavitha on Tuesday sent a ceremonial chadar to the Ajmer Sharif Dargah after holding special prayers in Hyderabad. She organised the event at the Telangana Jagruti office in Banjara Hills.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter and Instagram. For all the latest Hyderabad News update
